About
Technology
Issues
FAQ
Links
Official Page
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.